Gene: GNG14
Official Full Name: G protein subunit gamma 14provided by HGNC
Gene Summary: Predicted to enable G-protein beta-subunit binding activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to be located in plasma membrane. Predicted to be part of heterotrimeric G-protein complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17354 | GNG14 Knockout cell line (HEK293) | Human | GNG14 | 1:3~1:6 | Negative | Online Inquiry |
GNG14 Gene Knockout Cell Lines are precisely engineered, genetically modified cell lines designed to investigate the biological roles of the GNG14 gene, which plays a crucial role in G protein signaling pathways. By utilizing CRISPR-Cas9 technology for targeted gene disruption, these knockout cell lines provide researchers with the ability to elucidate the physiological and pathological effects of GNG14 loss-of-function in a reliable and controlled manner.
The key mechanism of the GNG14 knockout involves the specific alteration of the GNG14 gene locus, leading to a complete absence of functional GNG14 protein. This enables researchers to study the downstream effects of GNG14 deficiency on cellular signaling, gene expression, and metabolic processes. The resultant changes frequently offer insights into the gene's involvement in various diseases, including cancer and neurodegenerative disorders, making these cell lines invaluable for pathway elucidation and drug discovery.
From a scientific perspective, GNG14 knockout cell lines are particularly important as they facilitate advancements in understanding G protein-coupled receptor (GPCR) signaling. This information is crucial for the development of targeted therapies in clinical settings, highlighting their relevance in therapeutic discovery and biomarker development.
Distinct from traditional cell lines, GNG14 knockout cell lines offer several advantages: they provide a clean genetic background devoid of GNG14 activity, allowing for clearer interpretation of experimental results. Moreover, they serve as essential controls in screening assays for new pharmacological agents, which reduce the risk of misleading outcomes due to off-target effects.
The GNG14 Gene Knockout Cell Lines represent a valuable tool for researchers and clinicians alike, providing definitive solutions for understanding intricate cellular mechanisms and for the development of novel therapeutic strategies. At our company, we specialize in the production of high-quality, validated genetic models to empower scientific discovery, ensuring that our clients have the best resources available to advance their research goals.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.